Evidence map›Paper›PMID 41705495›Full record

ArticleBiomaterials science2026

Clickable polyamidosaccharides: accessing bottlebrush inspired hyaluronic acid glycopolymers for CD44 targeting of breast cancer cells.

Kaitlynn A Sockett, Madeline K Loffredo, Christian D DeMoya, Zoe G Garman, Mark W Grinstaff

Abstract read
In one paragraph

Article in Biomaterials science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kaitlynn A SockettDepartment of Chemistry, Boston University, Room 519, 590 Commonwealth Ave, Boston, MA 02215, USA. mgrin@bu.edu.ORCID http://orcid.org/0000-0003-2767-6716
Madeline K LoffredoDivision of Material Science and Engineering, Boston University, Boston, MA 02215, USA. msl@bu.edu.ORCID http://orcid.org/0000-0002-5003-2081
Christian D DeMoyaDepartment of Biomedical Engineering, Boston University, Boston, MA 02215, USA. cdemoya@bu.edu.ORCID http://orcid.org/0000-0001-6869-6188
Zoe G GarmanDepartment of Biomedical Engineering, Boston University, Boston, MA 02215, USA. cdemoya@bu.edu.ORCID http://orcid.org/0000-0001-7154-5313
Mark W GrinstaffDepartment of Chemistry, Boston University, Room 519, 590 Commonwealth Ave, Boston, MA 02215, USA. mgrin@bu.edu.ORCID http://orcid.org/0000-0002-5453-3668

Funding

Translational Research in BiomaterialsT32EB006359 · NIBIB · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI MARK W. GRINSTAFF, Michelle H Teplensky · 2009 to 2026
$4.2M
Disulfated polyamidosaccharide nanoparticles as a P-selectin targeting chemotherapeutic delivery systemF31CA298728 · NCI · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI Madeline Loffredo · 2025 to 2026
$93k
NCI NIH HHS F31 CA298728NIBIB NIH HHS T32 EB006359
6 · The paper itself

Abstract

Hyaluronic acid (HA) binds the transmembrane glycoprotein cluster of differentiation-44 (CD44), a highly expressed surface receptor that plays a critical role in tumor growth, invasion, and metastasis. Approaches to target CD44 utilize biologically sourced HA which inherently suffers from molecular weight (MW) heterogeneity and biological contaminants. Fully synthetic approaches to HA are attractive and circumvent these biological contaminants; however, readily accessing oligomers of six monosaccharides or more, as is required for CD44 binding, is challenging. To this end, we report the synthesis of glycopolymers functionalized with HA disaccharide pendant chains. These well-defined and regioselective polymers consist of glucose monomers linked

Indexed as

Breast NeoplasmsHyaluronan ReceptorsHyaluronic AcidPaclitaxelPolymersCell Line, TumorClick ChemistryFemaleHumansCD44 protein, humanHyaluronan ReceptorsHyaluronic AcidPaclitaxelPolymers

Identifiers

PMID41705495
PMCPMC12914647

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.